Filing Details
- Accession Number:
- 0001062993-11-002388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-26 20:21:13
- Reporting Period:
- 2011-05-24
- Filing Date:
- 2011-05-26
- Accepted Time:
- 2011-05-26 19:21:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1446201 | Matthew Geller | 248 Central Park West New York NY 10024 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-05-24 | 7,700 | $24.08 | 10,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.